Biomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients

Thumbnail Image

Date

2017

Authors

Babak, Oleg
Molodan, Volodymyr
Lapshyna, Kateryna
Prosolenko, Kostyantyn

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Plasma CK-18 and FGF-21 levels are increased in patients with NASH and also associate with atherogenic dyslipidemia and impaired liver enzyme activity. Study plasma levels of CK-18 and FGF21 allows to establish the presence of NASH in patients with NAFLD. The findings suggest the possibility of using these biomarkers for minimally invasive screening diagnosis of NASH and represent the perspective of further research.

Description

Keywords

NAFLD, hypertension

Citation

Biomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients /O. Y. Babak, V. I. Molodan, K. A. Lapshyna, K. O. Prosolenko // The New Armenian Medical Journal. – 2017. – Т. 11, № 2. – P. 46–51.

Endorsement

Review

Supplemented By

Referenced By